SCHEMBL16572032

SCHEMBL16572032

CCCCOC(=O)c1cccc(/C(N)=N\O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.52
▸ CYP2C19 P33261 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ LMNA P02545 3/20 0.52
▸ TSHR P16473 3/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ GAA P10253 2/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ PDE4D Q08499 1/20 0.52
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ HPGD P15428 1/20 0.51
▸ ESR1 P03372 7/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ NR1H2 P55055 1/20 0.50
▸ RNASEL Q05823 1/20 0.50
▸ TP53 P04637 2/20 0.49
▸ MAPT P10636 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111861 0.87 L3MBTL1 (0.64) CYP1A2CYP2C19RAB9ALMNATSHR
SCHEMBL12362249 0.86 TDP1 (0.45) CYP1A2CYP2C19RAB9ACYP2C9GAA
SCHEMBL12354563 0.86 TDP1 (0.45) CYP1A2CYP2C19RAB9ACYP2C9GAA
SCHEMBL6596210 0.85 CYP4F2 (0.51) CYP1A2CYP2C19RAB9ALMNATSHR
SCHEMBL6596214 0.85 CYP4F2 (0.51) CYP1A2CYP2C19RAB9ALMNATSHR
SCHEMBL7189257 0.85 L3MBTL1 (0.62) CYP1A2CYP2C19RAB9ALMNATSHR
Lithium SCHEMBL30876327 0.85 L3MBTL1 (0.62) CYP1A2CYP2C19RAB9ALMNATSHR
SCHEMBL12643428 0.85 TDP1 (0.47) RAB9ALMNAGAANPC1ESR1
SCHEMBL12586961 0.85 TDP1 (0.47) RAB9ALMNAGAANPC1ESR1
SCHEMBL12112450 0.84 TDP1 (0.46) RAB9ALMNAGAANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9481658-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2016-11-01 — — US disclosed
US-20150080582-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2015-03-19 — — US disclosed
US-8981108-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2015-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150080582-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND PYM1, CCND2, CCNB2 CYP1A2 1014/4885CYP2C19 2322/4885RAB9A 1682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback